Loading…
Defective immune adherence receptors (CR1) on erythrocytes in autoimmune diseases: An association with HLA–Cw3
A possible role of erythrocyte immune adherence receptor (C3b receptor, CR1) in removal of circulating immune complexes has been postulated. It has been reported that defective CR1 on erythrocytes was observed in the majority of the patients with systemic lupus erythematosus (SLE) but in only 5% of...
Saved in:
Published in: | Arthritis and rheumatism 1985-03, Vol.28 (3), p.349-351 |
---|---|
Main Authors: | , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c4008-c269b6a2ecb9a793ed6b78cf7add6fffe812e270169433bf010e8cde26e598d83 |
---|---|
cites | cdi_FETCH-LOGICAL-c4008-c269b6a2ecb9a793ed6b78cf7add6fffe812e270169433bf010e8cde26e598d83 |
container_end_page | 351 |
container_issue | 3 |
container_start_page | 349 |
container_title | Arthritis and rheumatism |
container_volume | 28 |
creator | Matsumura, Yukio Inokuma, Shigeko Hayakawa, Tetsuo Kisaki, Tomonari |
description | A possible role of erythrocyte immune adherence receptor (C3b receptor, CR1) in removal of circulating immune complexes has been postulated. It has been reported that defective CR1 on erythrocytes was observed in the majority of the patients with systemic lupus erythematosus (SLE) but in only 5% of normal subjects. The defect was suspected to be genetically determined because it was not affected by disease activity or the amount of circulating immune complexes, but stayed unchanged during the course of the disease even after years in remission induced by steroid therapy. The authors investigated a correlation between CR1 abnormality and the major histocompatibility antigens, HLA-A, B, C, and DR, and the authors noticed in a preliminary study that most patients with SLE who had defective CR1 also had HLA-Cw3, although the frequency of HLA-Cw3 among a Japanese population has been reported to be 46.5%. This study provides evidence for the association of defective CR1 with HLA-Cw3 tested in 73 subjects: 38 patients with autoimmune diseases and 35 of their consanguineous relatives. |
doi_str_mv | 10.1002/art.1780280318 |
format | article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_76040665</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>76040665</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4008-c269b6a2ecb9a793ed6b78cf7add6fffe812e270169433bf010e8cde26e598d83</originalsourceid><addsrcrecordid>eNqFkU1r3DAQhkVJSbZJr70VdAihPXgzkmxZym3ZfqSwUAjp2cjyiFXxx0aSs-yt_6H_sL-kDmvS3nIaNPO874h5CXnHYMkA-LUJaclKBVyBYOoVWbCC6wyYYCdkAQB5JgrNzsibGH9OTy4KcUpOBSukhGJBdp_QoU3-EanvurFHapotBuwt0oAWd2kIkX5Y37GPdOgphkPahsEeEkbqe2rGNMy6xkc0EeMNXU39GAfrTfKTZu_Tlt5uVn9-_V7vxQV57Uwb8e1cz8mPL5_v17fZ5vvXb-vVJrM5gMosl7qWhqOttSm1wEbWpbKuNE0jnXOoGEdeApM6F6J2wACVbZBLLLRqlDgnV0ffXRgeRoyp6ny02Lamx2GMVSkhBymLF0GWT7dS8slxeQRtGGIM6Kpd8J0Jh4pB9ZRFNWVR_ctiEryfnce6w-YZn48_zS_nuYnWtC6Y3vr4jGkOuZB8wvQR2_sWDy8srVZ39_994S_eOaO3</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>14156868</pqid></control><display><type>article</type><title>Defective immune adherence receptors (CR1) on erythrocytes in autoimmune diseases: An association with HLA–Cw3</title><source>Alma/SFX Local Collection</source><creator>Matsumura, Yukio ; Inokuma, Shigeko ; Hayakawa, Tetsuo ; Kisaki, Tomonari</creator><creatorcontrib>Matsumura, Yukio ; Inokuma, Shigeko ; Hayakawa, Tetsuo ; Kisaki, Tomonari</creatorcontrib><description>A possible role of erythrocyte immune adherence receptor (C3b receptor, CR1) in removal of circulating immune complexes has been postulated. It has been reported that defective CR1 on erythrocytes was observed in the majority of the patients with systemic lupus erythematosus (SLE) but in only 5% of normal subjects. The defect was suspected to be genetically determined because it was not affected by disease activity or the amount of circulating immune complexes, but stayed unchanged during the course of the disease even after years in remission induced by steroid therapy. The authors investigated a correlation between CR1 abnormality and the major histocompatibility antigens, HLA-A, B, C, and DR, and the authors noticed in a preliminary study that most patients with SLE who had defective CR1 also had HLA-Cw3, although the frequency of HLA-Cw3 among a Japanese population has been reported to be 46.5%. This study provides evidence for the association of defective CR1 with HLA-Cw3 tested in 73 subjects: 38 patients with autoimmune diseases and 35 of their consanguineous relatives.</description><identifier>ISSN: 0004-3591</identifier><identifier>EISSN: 1529-0131</identifier><identifier>DOI: 10.1002/art.1780280318</identifier><identifier>PMID: 3156605</identifier><identifier>CODEN: ARHEAW</identifier><language>eng</language><publisher>New York: John Wiley & Sons, Inc</publisher><subject>Autoimmune Diseases - genetics ; Autoimmune Diseases - immunology ; Autoimmune Diseases - pathology ; Biological and medical sciences ; complement component C3b ; General aspects ; histocompatibility antigen HLA ; HLA Antigens - analysis ; HLA-C Antigens ; Humans ; Immunopathology ; Lupus Erythematosus, Systemic - immunology ; man ; Medical sciences ; Pedigree ; receptors ; Receptors, Complement - genetics ; Receptors, Complement - physiology ; Receptors, Complement 3b ; systemic lupus erythematosus</subject><ispartof>Arthritis and rheumatism, 1985-03, Vol.28 (3), p.349-351</ispartof><rights>Copyright © 1985 American College of Rheumatology</rights><rights>1985 INIST-CNRS</rights><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4008-c269b6a2ecb9a793ed6b78cf7add6fffe812e270169433bf010e8cde26e598d83</citedby><cites>FETCH-LOGICAL-c4008-c269b6a2ecb9a793ed6b78cf7add6fffe812e270169433bf010e8cde26e598d83</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=9204362$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/3156605$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Matsumura, Yukio</creatorcontrib><creatorcontrib>Inokuma, Shigeko</creatorcontrib><creatorcontrib>Hayakawa, Tetsuo</creatorcontrib><creatorcontrib>Kisaki, Tomonari</creatorcontrib><title>Defective immune adherence receptors (CR1) on erythrocytes in autoimmune diseases: An association with HLA–Cw3</title><title>Arthritis and rheumatism</title><addtitle>Arthritis Rheum</addtitle><description>A possible role of erythrocyte immune adherence receptor (C3b receptor, CR1) in removal of circulating immune complexes has been postulated. It has been reported that defective CR1 on erythrocytes was observed in the majority of the patients with systemic lupus erythematosus (SLE) but in only 5% of normal subjects. The defect was suspected to be genetically determined because it was not affected by disease activity or the amount of circulating immune complexes, but stayed unchanged during the course of the disease even after years in remission induced by steroid therapy. The authors investigated a correlation between CR1 abnormality and the major histocompatibility antigens, HLA-A, B, C, and DR, and the authors noticed in a preliminary study that most patients with SLE who had defective CR1 also had HLA-Cw3, although the frequency of HLA-Cw3 among a Japanese population has been reported to be 46.5%. This study provides evidence for the association of defective CR1 with HLA-Cw3 tested in 73 subjects: 38 patients with autoimmune diseases and 35 of their consanguineous relatives.</description><subject>Autoimmune Diseases - genetics</subject><subject>Autoimmune Diseases - immunology</subject><subject>Autoimmune Diseases - pathology</subject><subject>Biological and medical sciences</subject><subject>complement component C3b</subject><subject>General aspects</subject><subject>histocompatibility antigen HLA</subject><subject>HLA Antigens - analysis</subject><subject>HLA-C Antigens</subject><subject>Humans</subject><subject>Immunopathology</subject><subject>Lupus Erythematosus, Systemic - immunology</subject><subject>man</subject><subject>Medical sciences</subject><subject>Pedigree</subject><subject>receptors</subject><subject>Receptors, Complement - genetics</subject><subject>Receptors, Complement - physiology</subject><subject>Receptors, Complement 3b</subject><subject>systemic lupus erythematosus</subject><issn>0004-3591</issn><issn>1529-0131</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1985</creationdate><recordtype>article</recordtype><recordid>eNqFkU1r3DAQhkVJSbZJr70VdAihPXgzkmxZym3ZfqSwUAjp2cjyiFXxx0aSs-yt_6H_sL-kDmvS3nIaNPO874h5CXnHYMkA-LUJaclKBVyBYOoVWbCC6wyYYCdkAQB5JgrNzsibGH9OTy4KcUpOBSukhGJBdp_QoU3-EanvurFHapotBuwt0oAWd2kIkX5Y37GPdOgphkPahsEeEkbqe2rGNMy6xkc0EeMNXU39GAfrTfKTZu_Tlt5uVn9-_V7vxQV57Uwb8e1cz8mPL5_v17fZ5vvXb-vVJrM5gMosl7qWhqOttSm1wEbWpbKuNE0jnXOoGEdeApM6F6J2wACVbZBLLLRqlDgnV0ffXRgeRoyp6ny02Lamx2GMVSkhBymLF0GWT7dS8slxeQRtGGIM6Kpd8J0Jh4pB9ZRFNWVR_ctiEryfnce6w-YZn48_zS_nuYnWtC6Y3vr4jGkOuZB8wvQR2_sWDy8srVZ39_994S_eOaO3</recordid><startdate>198503</startdate><enddate>198503</enddate><creator>Matsumura, Yukio</creator><creator>Inokuma, Shigeko</creator><creator>Hayakawa, Tetsuo</creator><creator>Kisaki, Tomonari</creator><general>John Wiley & Sons, Inc</general><general>Wiley</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7T5</scope><scope>8FD</scope><scope>FR3</scope><scope>H94</scope><scope>M7Z</scope><scope>P64</scope><scope>7X8</scope></search><sort><creationdate>198503</creationdate><title>Defective immune adherence receptors (CR1) on erythrocytes in autoimmune diseases: An association with HLA–Cw3</title><author>Matsumura, Yukio ; Inokuma, Shigeko ; Hayakawa, Tetsuo ; Kisaki, Tomonari</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4008-c269b6a2ecb9a793ed6b78cf7add6fffe812e270169433bf010e8cde26e598d83</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1985</creationdate><topic>Autoimmune Diseases - genetics</topic><topic>Autoimmune Diseases - immunology</topic><topic>Autoimmune Diseases - pathology</topic><topic>Biological and medical sciences</topic><topic>complement component C3b</topic><topic>General aspects</topic><topic>histocompatibility antigen HLA</topic><topic>HLA Antigens - analysis</topic><topic>HLA-C Antigens</topic><topic>Humans</topic><topic>Immunopathology</topic><topic>Lupus Erythematosus, Systemic - immunology</topic><topic>man</topic><topic>Medical sciences</topic><topic>Pedigree</topic><topic>receptors</topic><topic>Receptors, Complement - genetics</topic><topic>Receptors, Complement - physiology</topic><topic>Receptors, Complement 3b</topic><topic>systemic lupus erythematosus</topic><toplevel>online_resources</toplevel><creatorcontrib>Matsumura, Yukio</creatorcontrib><creatorcontrib>Inokuma, Shigeko</creatorcontrib><creatorcontrib>Hayakawa, Tetsuo</creatorcontrib><creatorcontrib>Kisaki, Tomonari</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Immunology Abstracts</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>Biochemistry Abstracts 1</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Arthritis and rheumatism</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Matsumura, Yukio</au><au>Inokuma, Shigeko</au><au>Hayakawa, Tetsuo</au><au>Kisaki, Tomonari</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Defective immune adherence receptors (CR1) on erythrocytes in autoimmune diseases: An association with HLA–Cw3</atitle><jtitle>Arthritis and rheumatism</jtitle><addtitle>Arthritis Rheum</addtitle><date>1985-03</date><risdate>1985</risdate><volume>28</volume><issue>3</issue><spage>349</spage><epage>351</epage><pages>349-351</pages><issn>0004-3591</issn><eissn>1529-0131</eissn><coden>ARHEAW</coden><abstract>A possible role of erythrocyte immune adherence receptor (C3b receptor, CR1) in removal of circulating immune complexes has been postulated. It has been reported that defective CR1 on erythrocytes was observed in the majority of the patients with systemic lupus erythematosus (SLE) but in only 5% of normal subjects. The defect was suspected to be genetically determined because it was not affected by disease activity or the amount of circulating immune complexes, but stayed unchanged during the course of the disease even after years in remission induced by steroid therapy. The authors investigated a correlation between CR1 abnormality and the major histocompatibility antigens, HLA-A, B, C, and DR, and the authors noticed in a preliminary study that most patients with SLE who had defective CR1 also had HLA-Cw3, although the frequency of HLA-Cw3 among a Japanese population has been reported to be 46.5%. This study provides evidence for the association of defective CR1 with HLA-Cw3 tested in 73 subjects: 38 patients with autoimmune diseases and 35 of their consanguineous relatives.</abstract><cop>New York</cop><pub>John Wiley & Sons, Inc</pub><pmid>3156605</pmid><doi>10.1002/art.1780280318</doi><tpages>3</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0004-3591 |
ispartof | Arthritis and rheumatism, 1985-03, Vol.28 (3), p.349-351 |
issn | 0004-3591 1529-0131 |
language | eng |
recordid | cdi_proquest_miscellaneous_76040665 |
source | Alma/SFX Local Collection |
subjects | Autoimmune Diseases - genetics Autoimmune Diseases - immunology Autoimmune Diseases - pathology Biological and medical sciences complement component C3b General aspects histocompatibility antigen HLA HLA Antigens - analysis HLA-C Antigens Humans Immunopathology Lupus Erythematosus, Systemic - immunology man Medical sciences Pedigree receptors Receptors, Complement - genetics Receptors, Complement - physiology Receptors, Complement 3b systemic lupus erythematosus |
title | Defective immune adherence receptors (CR1) on erythrocytes in autoimmune diseases: An association with HLA–Cw3 |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-30T09%3A50%3A10IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Defective%20immune%20adherence%20receptors%20(CR1)%20on%20erythrocytes%20in%20autoimmune%20diseases:%20An%20association%20with%20HLA%E2%80%93Cw3&rft.jtitle=Arthritis%20and%20rheumatism&rft.au=Matsumura,%20Yukio&rft.date=1985-03&rft.volume=28&rft.issue=3&rft.spage=349&rft.epage=351&rft.pages=349-351&rft.issn=0004-3591&rft.eissn=1529-0131&rft.coden=ARHEAW&rft_id=info:doi/10.1002/art.1780280318&rft_dat=%3Cproquest_cross%3E76040665%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c4008-c269b6a2ecb9a793ed6b78cf7add6fffe812e270169433bf010e8cde26e598d83%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=14156868&rft_id=info:pmid/3156605&rfr_iscdi=true |